Filing Details
- Accession Number:
- 0000903423-19-000257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-26 10:46:51
- Reporting Period:
- 2019-06-24
- Accepted Time:
- 2019-06-26 10:46:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1457612 | Genocea Biosciences Inc. | GNCA | Pharmaceutical Preparations (2834) | X0 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford Middlesex X0 TW8 9GS | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-24 | 1,857,142 | $3.50 | 3,365,884 | No | 4 | P | Indirect | See Footenote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footenote |
Footnotes
- S.R. One, Limited acquired 1,857,142 shares of Common Stock of Genocea Biosciences, Inc. (the "Issuer") in connection with the Issuer's public offering.
- The shares reported herein are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").